Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Oct 31, 2018
Open Peer Review Period: Nov 1, 2018 - Nov 9, 2018
Date Accepted: Jan 20, 2019
(closed for review but you can still tweet)
Use, Perspectives and Attitudes Regarding Diabetes Management Mobile Apps among Diabetes Patients and Diabetologists in China: A National Online Survey
ABSTRACT
Background:
The diabetes disease burden in China is heavy, and mobile apps have great potential for diabetes management. However, there is a lack of investigation of diabetes app use among Chinese diabetes patients and diabetologists. The perspectives and attitudes of diabetes patients and diabetologists regarding diabetes apps are also not clear.
Objective:
Our objectives were to investigate diabetes patients’ and diabetologists’ use, attitudes and perspectives, as well as patients’ needs, with respect to diabetes apps to provide information about the design of diabetes apps and how to best promote their use.
Methods:
Diabetes patients and diabetologists throughout China were surveyed on the WeChat (Tencent Corp) network using Sojump (Changsha ran Xing InfoTech Ltd) from January 23, 2018, to July 30, 2018. Differences among groups were compared using chi-square tests. Multivariate regression analysis was used to identify associations of demographic and basic disease information with app usage among adult patients.
Results:
Overall, 1276 individuals from 30 provincial administrative regions responded to the patient survey; among them, the overall app awareness rate was 29.94% (382/1276), and usage was 15.44% (197/1276). The usage was higher among type 1 diabetes (T1DM) patients than among type 2 diabetes (T2DM) patients (22.8%, 108/473 VS 10.8%, 79/733; P<0.001). Multivariate regression analysis showed that diabetes type, age, education, family income and location were associated with app use in adult patients. The need for and selection of diabetes apps were a little different between T1DM and T2DM patients. The reasons why patients discontinued the use of an app included limited time (29.9%, 59/197), complicated operations (25.4%, 50/197), ineffectiveness for glycemic control (24.4%, 48/197) and cost (19.3%, 38/197). Of the 610 responders to the diabetologist survey, 40.5% (247/610) recommended diabetes apps to patients, and 25.2% (153/608) used diabetes apps to manage patients. The greatest obstacles to diabetologists’ use of apps to manage diabetes patients include limited time (46.1% , 280/608), issues of legality (21.2%, 129/608), patients’ distrust (17.8%, 108/608) and issues with charging (10.9%, 66/608).
Conclusions:
The awareness and use of diabetes apps in Chinese diabetic patients and the proportion of diabetologists using diabetes apps to manage patients are low. Designing apps targeting different patient needs and conducting high-quality randomized controlled trials (RCT) will improve the effectiveness of apps, provide evidence for patients to choose suitable apps, and be conducive to the promotion of app use.
Citation
Per the author's request the PDF is not available.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.